IPO registrations (S-1, F-1) · Registrants

CapForce Inc.

SEC CIK
1293818 · filings on EDGAR ↗
Name on the registration
OPGEN INC
Former names
OPGEN INC (2004–2026)
Registration
Form S-1, first filed 2015-03-03, last 2023-07-14; 8 initial registrations, 17 amendments
Outcome
Final prospectus filed 2015-05-05; declared effective 2015-05-04; withdrawal requested 2023-09-28
Industry (SIC)
Services-Management Consulting Services 8742
Incorporated in
DE
Business address
UNIT L33A-7, TOWER A, MENARA UOA BANGSAR, NO. 5, JALAN BANGSAR UTAMA 1, Kuala Lumpur 59000
EIN
06-1614015
Ticker
CFOR (OTC)
EDGAR entity type
operating
Insiders and CEO pay
CapForce Inc. on the corporate pages

Offering terms

Proposed price range
$5.50–$6.50 per share (S-1/A filed 2015-04-28)
Final price
$6.00 per share, within the range (424B4 filed 2015-05-05, an initial public offering)
Shares sold
2,500,000
Gross proceeds
$15,000,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol OPGN
Lead underwriters
Maxim Group
Syndicate
National Securities Corporation

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 51

FiledFormWhat it isName as filedEDGAR
2015-03-03S-1S-1 (registration)OPGEN INC0001079973-15-000157 ↗
2015-03-20S-1/AS-1/A (amendment)OPGEN INC0001079973-15-000212 ↗
2015-04-06S-1/AS-1/A (amendment)OPGEN INC0001047469-15-003200 ↗
2015-04-14S-1/AS-1/A (amendment)OPGEN INC0001047469-15-003470 ↗
2015-04-17S-1/AS-1/A (amendment)OPGEN INC0001047469-15-003614 ↗
2015-04-23S-1/AS-1/A (amendment)OPGEN INC0001047469-15-003845 ↗
2015-04-28S-1/AS-1/A (amendment)OPGEN INC0001047469-15-004058 ↗
2015-04-30S-1/AS-1/A (amendment)OPGEN INC0001047469-15-004178 ↗
2015-05-01S-1/AS-1/A (amendment)OPGEN INC0001047469-15-004265 ↗
2015-05-04EFFECTEFFECT (declared effective)OPGEN INC9999999995-15-001208 ↗
2015-05-05424B4424B4 (final prospectus)OPGEN INC0001047469-15-004386 ↗
2016-07-20EFFECTEFFECT (declared effective)OPGEN INC9999999995-16-005199 ↗
2016-09-09EFFECTEFFECT (declared effective)OPGEN INC9999999995-16-005660 ↗
2017-06-01S-1S-1 (registration)OPGEN INC0001079973-17-000319 ↗
2017-06-29S-1/AS-1/A (amendment)OPGEN INC0001079973-17-000368 ↗
2017-07-11S-1/AS-1/A (amendment)OPGEN INC0001079973-17-000389 ↗
2017-07-12EFFECTEFFECT (declared effective)OPGEN INC9999999995-17-001793 ↗
2017-07-14424B4424B4 (final prospectus)OPGEN INC0001079973-17-000405 ↗
2017-12-18S-1S-1 (registration)OPGEN INC0001079973-17-000743 ↗
2018-01-31S-1/AS-1/A (amendment)OPGEN INC0001079973-18-000056 ↗
2018-02-01S-1MEFS-1MEF (added securities)OPGEN INC0001079973-18-000064 ↗
2018-02-01EFFECTEFFECT (declared effective)OPGEN INC9999999995-18-000307 ↗
2018-02-05424B4424B4 (final prospectus)OPGEN INC0001079973-18-000087 ↗
2018-04-12EFFECTEFFECT (declared effective)OPGEN INC9999999995-18-000809 ↗
2018-04-12EFFECTEFFECT (declared effective)OPGEN INC9999999995-18-000811 ↗
2019-03-01S-1S-1 (registration)OPGEN INC0001079973-19-000111 ↗
2019-03-13S-1/AS-1/A (amendment)OPGEN INC0001079973-19-000135 ↗
2019-03-21EFFECTEFFECT (declared effective)OPGEN INC9999999995-19-000483 ↗
2019-03-21EFFECTEFFECT (declared effective)OPGEN INC9999999995-19-000484 ↗
2019-03-25EFFECTEFFECT (declared effective)OPGEN INC9999999995-19-000516 ↗
2019-09-16S-1S-1 (registration)OPGEN INC0001553350-19-000952 ↗
2019-10-15S-1/AS-1/A (amendment)OPGEN INC0001079973-19-000512 ↗
2019-10-17S-1/AS-1/A (amendment)OPGEN INC0001079973-19-000524 ↗
2019-10-23EFFECTEFFECT (declared effective)OPGEN INC9999999995-19-002371 ↗
2019-10-25424B4424B4 (final prospectus)OPGEN INC0001079973-19-000538 ↗
2020-01-23EFFECTEFFECT (declared effective)OPGEN INC9999999995-20-000140 ↗
2020-02-07EFFECTEFFECT (declared effective)OPGEN INC9999999995-20-000294 ↗
2020-06-29EFFECTEFFECT (declared effective)OPGEN INC9999999995-20-001695 ↗
2020-12-04EFFECTEFFECT (declared effective)OPGEN INC9999999995-20-003416 ↗
2021-06-11EFFECTEFFECT (declared effective)OPGEN INC9999999995-21-002318 ↗
2021-08-19EFFECTEFFECT (declared effective)OPGEN INC9999999995-21-003253 ↗
2022-12-01S-1S-1 (registration)OPGEN INC0001079973-22-001490 ↗
2022-12-30S-1/AS-1/A (amendment)OPGEN INC0001079973-22-001583 ↗
2023-01-05S-1/AS-1/A (amendment)OPGEN INC0001079973-23-000021 ↗
2023-01-06EFFECTEFFECT (declared effective)OPGEN INC9999999995-23-000050 ↗
2023-04-07S-1S-1 (registration)OPGEN INC0001079973-23-000458 ↗
2023-04-27S-1/AS-1/A (amendment)OPGEN INC0001079973-23-000559 ↗
2023-05-01EFFECTEFFECT (declared effective)OPGEN INC9999999995-23-001207 ↗
2023-07-14S-1S-1 (registration)OPGEN INC0001079973-23-000959 ↗
2023-09-28RWRW (withdrawal request)OPGEN INC0001079973-23-001332 ↗
2023-11-22EFFECTEFFECT (declared effective)OPGEN INC9999999995-23-003423 ↗

Prospectus pages read 4

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2015-04-28S-1/Aregistration statement$5.50–$6.50$6.002,500,000$15,000,0002primary document; range, price sentence, shares headline, proceeds computed, cover names 2document ↗
2015-04-30S-1/Aregistration statement--0primary document; no terms founddocument ↗
2015-05-01S-1/Aregistration statement--0primary document; no terms founddocument ↗
2015-05-05424B4final prospectus$6.002,500,000$15,000,000Nasdaq OPGN2primary document; price sentence, shares headline, proceeds computed, cover names 2document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
ATWOOD BRIAN GDirector; Director,TenPercentOwner32015–2016
DEC TIMOTHY COfficerCheif Financial Officer; Chief Financial Officer192015–2021person page Fuzzy
HARRIS & HARRIS GROUP INC /NY/TenPercentOwner22015
Harris Timothy J.R.Director82015–2018
Howe TimothyDirector22015
JONES EVAN/ FADirector; Director,Officer; Director,Officer,TenPercentOwner; OfficerChief Executive Officer222015–2021
jVen Capital, LLCDirector,Officer,TenPercentOwner; TenPercentOwnerChairman and CEO92015–2017
KRENITSKY KEVINOfficerPresident62015–2016
McCarthy LaurenceDirector32015–2016
Ushio MistiDirector72015–2019
Versant Side Fund III, L.P.TenPercentOwner22015
Versant Venture Capital III, L.P.TenPercentOwner22015
Versant Ventures III, LLCTenPercentOwner22015
Rubin DavidDirector12015
Merck & Co., Inc.TenPercentOwner42015–2018
Merck Global Health Innovation Fund, LLCTenPercentOwner42015–2018
Merck Sharp & Dohme Corp.TenPercentOwner42015–2018
D'Andrea Harry JDirector62016–2018
Nova Tina SusanDirector52017–2019
Sapiro Vadim M.OfficerChief Information Officer42017–2019
Elsey R DonDirector62019–2023person page Fuzzy
Bacher JohannesOfficerChief Operating Officer112020–2023
Crovetto MarioDirector52020–2023
Fernandes PrabhavathiDirector52020–2023
Rhodes William E.Director52020–2023
Schacht OliverDirector,OfficerChief Executive Officer102020–2023
Curetis N.V. in LiquidationTenPercentOwner42020
Weber AlbertOfficerChief Finanical Officer32022–2023
Schlaeppi YvonneDirector32022–2023
Ben-Tzvi AvrahamDirector22024
Lazar David E.Director,Officer,TenPercentOwnerChief Executive Officer72024
McMurdo Matthew CharlesDirector22024
NATAN DAVIDDirector22024
AEI Capital LtdTenPercentOwner42024–2025
Azudin Mohd AzhamOfficerCOO32024–2026
Bonte Christian-LaurentDirector; OfficerChief Executive Officer32024–2025
Chua Kok Hoe VictorDirector32024–2026
Lim Zhao Qi KenDirector32024–2026
Low Yu Jie EthanDirector32024–2026
Wong Poh Yin ConstanceDirector32024–2026
Yee Gillian Tan RouOfficerCorporate Secretary32024–2026
Syed Mohd Syed Johan BinOfficerChief Technology Officer; Chief Technology Officer (CTO)22025

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2022-10-12OPGEN INCBiotechnology$3,381,338$3,381,33811
2021-02-24OPGEN INCBiotechnology$25,000,000$25,000,00011
2020-12-04OPGEN INCBiotechnology$10,000,000$9,974,02711
2018-08-03OPGEN INCBiotechnology$285,512$285,51211
2017-09-21OPGEN INCBiotechnology$110,000$110,00011
2017-06-20OPGEN INCBiotechnology$1,500,000$500,00021
2016-05-27OPGEN INCBiotechnology$10,355,005$7,227,504101
2015-07-23OPGEN INCBiotechnology$2,584,090$2,584,09041
2015-02-23OPGEN INCBiotechnology$1,500,000$1,243,99991
2014-07-17OPGEN INCBiotechnology$1,500,000$1,079,91741
2014-04-04OPGEN INCBiotechnology$4,000,000$3,999,864291
2012-03-14OPGEN INCBiotechnology$17,000,000$6,100,000281
2012-02-16OPGEN INCBiotechnology$3,699,209$3,532,442271

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationOPGEN, INC.MDState business registriesEIN (EXACT, as the state registration reports it)
Form D issuerOPGEN INCMDForm D private offeringsCIK (EXACT)
SEC filerCapForce Inc.SEC filers (EDGAR)CIK (EXACT)
Form 5500 plan sponsorOPGEN INC.EIN (EXACT)
Person pageR Don ElseyPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director)
Person pageTimothy C DecPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.